La deficiencia de colágeno tipo III es una deficiencia de colágeno tipo III.

Same author

Comprehensive genetic diagnosis and therapeutic perspectives in 155 children with developmental and epileptic encephalopathy.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2025

Same author

Mother and daughter with Kenny-Caffey syndrome: the adult phenotype.

European journal of medical genetics·2024

Same author

[The transition from pediatric care to the doctor and that of the adult, or the importance of "bridging the gap"].

Revue medicale suisse·2015

Same author

[Does prematurity affect adulthood?].

Revue medicale suisse·2014

Same author

Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA.

European journal of neurology·2012

Same author

[Why does knowledge on rare diseases allow progress in treatments?].

Revue medicale suisse·2012

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

La deficiencia de colágeno tipo III es una deficiencia de colágeno tipo III.

Videos de Conceptos Relacionados

Comprehensive genetic diagnosis and therapeutic perspectives in 155 children with developmental and epileptic encephalopathy.

Mother and daughter with Kenny-Caffey syndrome: the adult phenotype.

[The transition from pediatric care to the doctor and that of the adult, or the importance of "bridging the gap"].

[Does prematurity affect adulthood?].

Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA.

[Why does knowledge on rare diseases allow progress in treatments?].

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

La deficiencia de colágeno tipo III es una deficiencia de colágeno tipo III.

Videos de Conceptos Relacionados

Artículos Relacionados

Comprehensive genetic diagnosis and therapeutic perspectives in 155 children with developmental and epileptic encephalopathy.

Mother and daughter with Kenny-Caffey syndrome: the adult phenotype.

[The transition from pediatric care to the doctor and that of the adult, or the importance of "bridging the gap"].

[Does prematurity affect adulthood?].

Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA.

[Why does knowledge on rare diseases allow progress in treatments?].

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.